Tilray Brands (TLRY) is a CA-listed Healthcare company in Drug Manufacturers - Specialty & Generic with a market capitalization of $511M, trading at $4.26 on the NASDAQ. This SniperIQ fundamentals page covers Tilray Brands's valuation, profitability (net margin -156.2%), revenue (
.1B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Market Cap$511M
Net Margin-156.2%
Revenue (FY25)
.1B
Full research coverage
8-Quarter Revenue & Margin Trend
Debt Maturity & Coverage
Peer Valuation Comparison
Free Cash Flow & Owner Earnings
AI Signal + Institutional Flow
DCF Valuation Model
Frequently Asked Questions
What is Tilray Brands's market cap?
Tilray Brands (TLRY) has a market capitalization of approximately $511M, trading at $4.26 on the NASDAQ. Market cap moves with the live share price.
What is Tilray Brands's P/E ratio?
Tilray Brands's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 0.3x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Tilray Brands?
Tilray Brands runs a net profit margin of -156.2%, a gross margin of 27.7%, and an operating margin of -172.3%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Tilray Brands generate?
Tilray Brands reported revenue of
.1B for fiscal year 2025, with net income of -
.0B and earnings per share (EPS) of -33.8. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Tilray Brands pay a dividend?
Tilray Brands does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Tilray Brands financially healthy?
Tilray Brands carries a debt-to-equity ratio of 0.20x and a current ratio of 2.79x, with a market beta of 1.90. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Tilray Brands a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Tilray Brands (TLRY) the key facts are: market cap $511M, revenue
.1B, 52-week range 4.2-23.2. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Tilray Brands's full fundamentals live
Get Tilray Brands's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.